Loading...
XMEX
MEDICAB
Market cap365mUSD
Jul 06, Last price  
59.40MXN
1D
-2.25%
1Q
-2.96%
Jan 2017
40.43%
Name

Medica Sur, S.A.B. De C.V.

Chart & Performance

D1W1MN
XMEX:MEDICAB chart
P/E
11.87
P/S
1.34
EPS
5.01
Div Yield, %
2.53%
Shrs. gr., 5y
-2.60%
Rev. gr., 5y
1.41%
Revenues
4.79b
+8.77%
1,224,235,6481,397,174,4901,556,154,7551,784,449,4111,822,723,9751,900,834,0932,089,975,6842,256,399,6122,292,095,9952,278,751,6022,590,272,6123,431,445,8463,607,605,8393,698,067,6774,466,185,9343,906,143,7753,867,922,4284,129,754,0004,402,820,0004,788,891,000
Net income
540m
+17.06%
194,246,154216,324,806193,732,240236,829,900231,326,985224,088,054300,513,456379,765,048349,084,341241,018,529142,634,010231,798,220169,295,459140,551,783558,827,8221,154,516,740949,802,530634,983,587461,509,000540,249,000
CFO
969m
+62.89%
311,868,812305,416,639306,190,243427,755,325316,393,450349,721,873344,107,405494,095,240474,579,657327,807,240198,782,141213,985,864305,898,124425,440,5801,101,315,918821,320,259270,090,208423,871,328594,873,000968,988,000
Dividend
May 19, 20251.5 MXN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Médica Sur, S.A.B. de C.V. functions as a leading healthcare provider within Mexico. The institution furnishes a comprehensive array of medical and surgical treatments, including intricate procedures such as bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast augmentation, stereotactic radiosurgery, hip arthroplasty, knee and shoulder arthroscopy, spinal operations, lithiasis removal, and various prostate interventions, notably radical prostatectomy. Beyond these surgical offerings, Médica Sur also extends its services to include advanced radiotherapy, diagnostic imaging, comprehensive health check-ups, and medical insurance solutions. Established in 1966, this entity is headquartered in Mexico City and operates as a subsidiary of Neuco, SA de CV.
IPO date
Mar 10, 1994
Employees
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT